| PRD_002311 | Name: | ACE-MVA-MP8-NZC-LEU-MP8-LEU-MVA-PRO-MLU-GLY | Formula: | C57 H96 N10 O12 | Definition date: | 2019-05-29 | Last modified: | 2019-05-29 |
|
| PRD_002312 | Name: | (GZJ)VDINNN(CY3) Cyclic peptide inhibitor | Formula: | C36 H58 N12 O14 S | Definition date: | 2019-04-17 | Last modified: | 2019-04-17 |
|
| PRD_002319 | Name: | (6D6)PPKRIA(NH2), DC100-1 | Formula: | C48 H84 N18 O11 | Definition date: | 2019-04-03 | Last modified: | 2019-04-03 |
|
| PRD_002316 | Name: | Apollo peptide | Formula: | C46 H68 N8 O7 | Definition date: | 2019-02-13 | Last modified: | 2019-02-13 |
|
| PRD_002284 | Formula: | C37 H57 N11 O11 | Definition date: | 2018-11-07 | Last modified: | 2018-11-07 |
|
| PRD_002328 | Name: | TYROSTATIN (Bound Form) | Formula: | C29 H41 N3 O6 | Definition date: | 2018-10-24 | Last modified: | 2018-10-31 |
|
| PRD_002327 | Name: | PSEUDOTYROSTATIN (Bound Form) | Formula: | C23 H30 N2 O5 | Definition date: | 2018-10-24 | Last modified: | 2018-10-24 |
|
| PRD_002331 | Name: | Chymostatin A (bound form) | Formula: | C31 H43 N7 O6 | Definition date: | 2018-10-24 | Last modified: | 2018-10-24 |
|
| PRD_002317 | Name: | N-Me-p-iodo-D-Phe1,N-Me-D-Gln4,Lys10-teixobactin analogue | Formula: | C59 H99 I N13 O15 | Definition date: | 2018-10-17 | Last modified: | 2018-10-17 |
|
| PRD_002323 | Name: | N-METHYL-4-HYDROXY-LEUCINE CYCLOSPORIN | Formula: | C62 H111 N11 O13 | Definition date: | 2018-09-12 | Last modified: | 2018-09-12 |
|
| PRD_002324 | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | Formula: | C62 H111 N11 O13 | Definition date: | 2018-09-12 | Last modified: | 2018-09-12 |
|
| PRD_002318 | Name: | SRC2-BCP1 | Formula: | C64 H109 N19 O15 | Definition date: | 2018-07-25 | Last modified: | 2018-07-25 |
|
| PRD_002279 | Name: | N-acetyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl-N-[(1R,4S,7S,10S,19S,22S,25S,28R)-28-{[(2R)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl}-25-(3-amino-3-oxopropyl)-4-[(1H-imidazol-3-ium-4-yl)methyl]-10,19-dimethyl-7,22-bis(2-methylpropyl)-3,6,9,20,23,26,30,36-octaoxo-2,5,8,21,24,27,31,37-octaazabicyclo[17.16.2]heptatriacontan-31-ium-10-yl]-6-azaniumyl-L-norleucinamide | Formula: | C64 H109 N19 O15 | Definition date: | 2018-06-13 | Last modified: | 2018-06-13 |
|
| PRD_002308 | Name: | DAMGO | Formula: | C26 H35 N5 O6 | Definition date: | 2018-06-13 | Last modified: | 2018-06-13 |
|
| PRD_002303 | Name: | [(3-{(3S,6S,9S,15R,20aS)-15-[(N-acetyl-L-phenylalanyl)amino]-3-(cyclohexylmethyl)-6-[(1H-indol-3-yl)methyl]-1,4,7,10,16-pentaoxoicosahydropyrrolo[1,2-a][1,4,7,10,13]pentaazacyclooctadecin-9-yl}propyl)amino](amino)methaniminium | Formula: | C47 H66 N11 O7 | Definition date: | 2018-05-30 | Last modified: | 2018-05-30 |
|
| PRD_001186 | Name: | Myosin-A, stapled peptide | Formula: | C97 H175 N31 O23 S | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | Definition date: | 2013-11-06 | Last modified: | 2017-12-15 |
|
| PRD_002230 | Name: | L-alpha-aspartyl-6-azaniumyl-L-norleucyl-O-phosphono-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-valyl-N-{(3R)-6-{[amino(iminio)methyl]amino}-1-[2-(methoxycarbonyl)-3,5-dimethylphenyl]-2-oxohexan-3-yl}glycinamide | Formula: | C48 H81 N12 O18 P | Definition date: | 2016-05-04 | Last modified: | 2017-12-15 |
|
| PRD_002275 | Formula: | C35 H59 N14 O13 | Definition date: | 2017-06-14 | Last modified: | 2017-12-15 |
|
| PRD_002277 | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | Formula: | C64 H93 N23 O25 S3 | Definition date: | 2017-08-30 | Last modified: | 2017-12-15 |
|
| PRD_002263 | Name: | N-[(1S)-1-cyclohexyl-2-{[3-(morpholin-4-yl)propanoyl]amino}ethyl]-N~2~-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alaninamide | Formula: | C31 H47 N5 O4 S | Definition date: | 2017-11-01 | Last modified: | 2017-11-01 |
|
| PRD_001141 | Name: | (3S,8aR)-N-((R)-chroman-4-yl)-2-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | Formula: | C29 H43 N5 O4 | Definition date: | 2013-08-28 | Last modified: | 2017-09-14 |
|
| PRD_002261 | Formula: | C92 H138 N27 O24 S | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | Definition date: | 2017-05-24 | Last modified: | 2017-05-24 |
|
| PRD_001131 | Name: | GRAMICIDIN A | Formula: | C90 H133 N19 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_001132 | Name: | CYCLOSPORIN D | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_002251 | Name: | 3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | Formula: | C34 H50 N4 O8 | Definition date: | 2017-01-25 | Last modified: | 2017-05-04 |
|